» Articles » PMID: 36727367

Incidence, Outcomes, and Risk of Surgical Failure After Development of Early Hypotony Following Aurolab Aqueous Drainage Implant Surgery

Overview
Specialty Ophthalmology
Date 2023 Feb 2
PMID 36727367
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To report the incidence, outcomes, and risk of surgical failure after early postoperative hypotony following Aurolab Aqueous Drainage Implant (AADI) surgery for adult and pediatric refractory glaucoma.

Methods: Medical records of patients who underwent AADI between January 2013 and March 2017 with a minimum of 2-years follow-up were retrospectively reviewed. Early postoperative hypotony was defined as IOP ≤5 mmHg within the first 3 months after AADI. Surgical failure of AADI was defined as IOP >21 mmHg or reduced <20% below baseline on two consecutive follow-up visits after 3 months, IOP ≤5 mmHg on two consecutive follow-up visits after 3 months, reoperation for glaucoma or a complication, or loss of light perception vision.

Results: Early postoperative hypotony was seen in 15/213 eyes (7%) in the adult group and in 6/101 eyes (6%) in the pediatric group. The onset of hypotony was significantly earlier in the pediatric group (median = 39 days post AADI, IQR = 20-58 days) compared with adult eyes (median = 51 days post AADI, IQR = 30-72 days) (P = 0.02). Eyes with early postoperative hypotony did not have an increased risk of cumulative surgical failure as compared with eyes without hypotony in both adult (33.3% vs. 23.7%; P = 0.48) and pediatric (33.3% vs. 13.7%; P = 0.16) refractory glaucoma. All eyes recovered from hypotony, though one adult eye developed retinal detachment and one pediatric eye developed corneal decompensation and lost vision.

Conclusion: Early postoperative hypotony was an infrequent complication post AADI and occurred earlier in pediatric eyes. Early postoperative hypotony did not increase risk of surgical failure up to 2 years.

Citing Articles

Commentary: Countering the hype related to hypotony in nonvalved Aurolab aqueous drainage implant.

Pathak Ray V Indian J Ophthalmol. 2023; 71(2):593-594.

PMID: 36727368 PMC: 10228974. DOI: 10.4103/ijo.IJO_2284_22.

References
1.
Pathak Ray V, Rao D . Two-Year Outcomes of the New Low-cost Nonvalved Aurolab Aqueous Drainage Implant in Refractory Glaucoma. J Glaucoma. 2020; 29(9):767-772. DOI: 10.1097/IJG.0000000000001532. View

2.
Puthuran G, Palmberg P, Wijesinghe H, Srivastav K, Krishnadas S, Robin A . Aurolab Aqueous Drainage Implant With and Without Scleral Patch Graft in Refractory Adult and Pediatric Glaucomas: A Comparative Study. Am J Ophthalmol. 2020; 216:226-236. DOI: 10.1016/j.ajo.2020.03.022. View

3.
Wijesinghe H, Puthuran G, Gedde S, Pradhan C, Uduman M, Krishnadas S . Incidence and Outcomes of Suprachoroidal Hemorrhage Following Aurolab Aqueous Drainage Implant in Adult and Pediatric Glaucoma. J Glaucoma. 2020; 30(6):497-501. DOI: 10.1097/IJG.0000000000001761. View

4.
Puthuran G, Palmberg P, Wijesinghe H, Pallamparthy S, Krishnadas S, Robin A . Intermediate-term outcomes of Aurolab aqueous drainage implant in refractory paediatric glaucoma. Br J Ophthalmol. 2019; 104(7):962-966. DOI: 10.1136/bjophthalmol-2019-314399. View

5.
Senthil S, Gollakota S, Ali M, Turaga K, Badakere S, Krishnamurthy R . Comparison of the New Low-Cost Nonvalved Glaucoma Drainage Device with Ahmed Glaucoma Valve in Refractory Pediatric Glaucoma in Indian Eyes. Ophthalmol Glaucoma. 2020; 1(3):167-174. DOI: 10.1016/j.ogla.2018.07.001. View